RudaCure held its company-wide New Year ceremony at the 首尔 office on the first Monday of January 2025.
At the ceremony, CEO Yongho Kim declared preparations for IPO and presented goals including system reorganization for IPO, technology advancement, successful progression of ongoing RCI001 临床试验 to the next phase, 技术转让 through non-clinical 毒性研究 for pain drug RCI002, and successful PoC for 兽药 RCI001AH.
Celebrating the 7th anniversary of the company's founding in 2025, the team celebrated the promotion of Assistant Manager Young-ah Ku to Manager and staff member Dongho Kwak to Assistant Manager. For outstanding results over the past year, Seunghyuk Choi was awarded as 优秀员工, and Assistant Manager Chanhee Choi was selected as 模范员工 for exemplary conduct.
We wish all RudaCure employees a prosperous 2025 filled with great achievements and hope it will be a year of meaningful growth.
